Newlink Genetics reported $29.7M in Market Capitalization this January of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agenus AGEN:US USD 581M 57M
Bristol Myers Squibb BMY:US USD 151.8B 12.14B
Capricor Therapeutics CAPR:US USD 148M 63M
Celldex Therapeutics CLDX:US USD 1.32B 53M
Eli Lilly And LLY:US USD 307.24B 831M
Idera Pharmaceuticals IDRA:US USD 23M 1000K
Intrexon XON:US USD 441M 163M
Merk MRK:US USD 218.17B 12.39B
Nektar Therapeutics NKTR:US USD 600M 108M
Newlink Genetics NLNK:US USD 74M 9M
Pfizer PFE:US USD 245.6B 48.58B
Prothena PRTA:US USD 2.84B 1.57B
Sarepta Therapeutics SRPT:US USD 9.68B 3.12B
Vascular Biogenics VBLT:US USD 11M 101M
YTE INCY:US USD 14.82B 2.01B